Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Blood Markers and ECG Patterns Could Provide Early Warning for Hidden Heart Risks in ICUs

By LabMedica International staff writers
Posted on 20 Aug 2025

Takotsubo cardiomyopathy (TTS), also known as Broken Heart syndrome, is a serious heart condition that mimics a heart attack but is triggered by extreme physical or emotional stress. More...

It causes temporary changes in how the left ventricle pumps and, if untreated, can lead to life-threatening complications such as fluid buildup in the lungs, cardiac arrest, or sudden death. In intensive care units (ICUs), the syndrome is often overlooked due to a lack of clear clinical pathways, putting critically ill patients at greater risk. Now, new research reveals that using electrocardiogram (ECG) patterns and blood markers could provide an early warning system for TTS in ICU patients.

The research by the University of South Australia (Adelaide, Australia) highlights gaps in ICU-specific TTS assessment practices, suggesting that developing a tailored clinical pathway, followed by validation, could support early recognition and management of TTS in ICU settings, enabling timely intervention and enhancing patient outcomes.. The study also emphasizes the role of critical care nurses with advanced ECG skills, who can detect subtle changes during routine checks and alert medical teams promptly.

The researchers conducted a review of the diagnostic strategies currently used to distinguish TTS from other cardiac events. Fourteen studies relied on ECG patterns, eleven examined blood biomarkers, and five employed heart imaging to capture temporary changes in cardiac function. The findings, published in Science Direct, demonstrate that integrating these tools into a structured clinical pathway could significantly improve recognition and timely treatment of the condition in critically ill patients.

Reported cases of TTS in ICUs vary from 1.5% to 28%, suggesting that inconsistent detection contributes to underdiagnosis. By combining existing diagnostic methods into an ICU-specific clinical pathway, the study proposes a model for earlier intervention. The research team has already developed a proposed pathway, which is now under review by clinical teams before implementation. This work underlines the importance of empowering ICU staff, particularly critical care nurses, to identify early signs of Takotsubo syndrome. Establishing standardized pathways would ensure timely treatment and reduce preventable complications.

“Early recognition can be the difference between recovery and a potentially fatal complication. We have the tools – now we need to integrate them into ICU care,” said Vicky Visvanathan, lead researcher and critical care nurse at the University of South Australia.

Related Links:
University of South Australia


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.